- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 15/12 - Gènes codant pour des protéines animales
Détention brevets de la classe C12N 15/12
Brevets de cette classe: 4716
Historique des publications depuis 10 ans
|
97
|
101
|
152
|
201
|
232
|
208
|
229
|
256
|
293
|
32
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 20378 |
56 |
| Kyoto University | 2877 |
51 |
| Regeneron Pharmaceuticals, Inc. | 4523 |
50 |
| Spiber Inc. | 296 |
44 |
| Osaka University | 3358 |
40 |
| University Health Network | 1061 |
40 |
| Universite de Montreal | 342 |
36 |
| Keio University | 1115 |
27 |
| Riken | 1704 |
27 |
| The Johns Hopkins University | 5774 |
26 |
| Institute of Materia Medica, Chinese Academy of Medical Sciences | 184 |
26 |
| The University of Tokyo | 4291 |
25 |
| The Trustees of the University of Pennsylvania | 4384 |
24 |
| The University of British Columbia | 1538 |
24 |
| The General Hospital Corporation | 4798 |
20 |
| Takeda Pharmaceutical Company Limited | 2713 |
20 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2945 |
20 |
| Biocytogen Pharmaceuticals (Beijing) Co., Ltd | 209 |
20 |
| Xlifesc, Ltd. | 47 |
20 |
| Kao Corporation | 5027 |
19 |
| Autres propriétaires | 4101 |